The ITAC investigators will assess whether giving people anti-coronavirus hyperimmune globulin at the onset of COVID-19 symptoms could augment the natural—and possibly delayed—antibody ...

New data have further strengthened the link between human immune globulin products and the risk for thrombosis, prompting action by the US Food and Drug Administration (FDA). "Additional caution ...

NIAID has initiated a Phase 3 clinical trial to evaluate the efficacy and safety of hyperimmune globulin products, including Emergent’s COVID-19 Human Immune Globulin (COVID-HIG), for potential ...